First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A.M.C. Dingemans, A.J. de Langen, V. van den Boogaart, J.T. Marcus, W.H. Backes, H.T.G.M. Scholtens, H. van Tinteren, O.S. Hoekstra, J. Pruim, B. Brans, F.B. Thunnissen, E.F. Smit, H.J.M. Groen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)559-566
JournalAnnals of Oncology
Volume22
Issue number3
DOIs
Publication statusPublished - 2011

Cite this